Key facts
- This page summarizes Matthew W. Strobeck's Form 4 filing for Accelerate Diagnostics, Inc (AXDX).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 29 Jun 2023, 17:55.
Matthew W. Strobeck - 28 Jun 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)
- Form type
- 4
- Filing time
- 29 Jun 2023, 17:55:36 UTC
- Previous filing
- 08 Jun 2023
- Next filing
- 07 Aug 2023
- SEC filing
- View on sec.gov
- Signature
- /s/ David Patience, attorney-in-fact
SEC evidence
5 facts
Reporting owner
1 fact
Key filing fact
Matthew W. Strobeck filed Form 4 for Accelerate Diagnostics, Inc (AXDX) on 29 Jun 2023.
Change
- Previous filing in this sequence was filed on 08 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
AXDX
transaction
Derivative
Employee Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +236,842
- Change %
- Price
- $0.000000
- Shares after
- 236,842
- Date
- 28 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 236,842
- Exercise price
- Footnotes
- F1, F2, F3
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. |
| F2 | On June 28, 2023, the reporting person was granted RSUs which vest in equal amounts each year for 5 years, with the first installment vesting on June 28, 2024. |
| F3 | Not applicable. |